185P Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study
Federico Rossari, Toshifumi Tada, S. Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, F. Finkelmeier, Ho Yeong Lim, José Presa, Gianluca Masi, F. Bergamo, Elisabeth Amadeo, Francesco Vitiello, Silvia Foti, M. Persano, F. Piscaglia, M. Scartozzi, S. Cascinu, M. Rimini, A. Casadei Gardini (2023). 185P Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A real-world, multicenter study. , 34, DOI: https://doi.org/10.1016/j.annonc.2023.10.764.
